NewsShelter Pharma Limited Confirms Non-Applicability of Annual Secretarial Compliance Report Under Regulation 24AShelter Pharma Limited Confirms Non-Applicability of Annual Secretarial Compliance Report Under Regulation 24A
Shelter Pharma Limited has notified BSE Limited about the non-applicability of Annual Secretarial Compliance report under Regulation 24A, citing its SME platform listing status. As per Regulation 15(2) of SEBI LODR 2015, the company is exempt from multiple regulatory provisions including Regulation 24A. The communication was officially signed by Managing Director Mustaqim Nisarahmed Sabugar on April 14th, 2026.
*this image is generated using AI for illustrative purposes only.
Shelter Pharma Limited has officially communicated to BSE Limited regarding the non-applicability of certain regulatory compliance requirements for SME-listed entities. The company has clarified its exemption status from Annual Secretarial Compliance report under Regulation 24A of SEBI regulations.
Regulatory Exemption Details
The company has informed BSE that as an entity listed on the BSE SME Platform, it is exempt from compliance with multiple SEBI regulations. According to Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, SME-listed entities are not required to comply with specific regulatory provisions.
| Exemption Details: | Information |
|---|---|
| Platform: | BSE SME Platform |
| Script Code: | 543963 |
| Applicable Regulation: | 15(2) of SEBI LODR 2015 |
| Communication Date: | April 14th, 2026 |
Scope of Regulatory Exemptions
The exemptions cover a comprehensive range of SEBI regulations for SME-listed entities. These include regulations related to corporate governance, board composition, and compliance reporting requirements that typically apply to main board listed companies.
The specific regulations from which the company is exempt include:
- Regulations 17, 17A, 18, 19, 20, 21, 22, 24, 24A, 25, 26, 27
- Clause (b) to (i) of sub regulation (2) of Regulation 46
- Para C, D, F and E of Schedule V of SEBI LODR Regulations
Official Communication
The formal communication was submitted to BSE Limited at Floor 25, P J Towers, Dalal Street, Mumbai. The letter was digitally signed by Mustaqim Nisarahmed Sabugar, Managing Director of the company, bearing DIN: 01456841.
| Communication Details: | Information |
|---|---|
| Signatory: | Mustaqim Nisarahmed Sabugar |
| Designation: | Managing Director |
| DIN: | 01456841 |
| Date: | April 14th, 2026 |
| Place: | Ahmedabad |
The company has requested BSE to take this information on record, confirming its understanding and compliance with the applicable regulatory framework for SME-listed entities. This communication ensures transparency regarding the company's regulatory obligations and exemptions under the current SEBI framework for SME platforms.
Historical Stock Returns for Shelter Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.57% | -0.62% | +2.54% | -26.57% | -21.22% | -23.02% |
Will SEBI consider tightening regulatory exemptions for SME-listed companies following recent corporate governance concerns in the sector?
How might Shelter Pharma's reduced compliance burden impact its operational costs and competitive positioning against main board pharmaceutical companies?
Could this regulatory exemption status influence institutional investor appetite for Shelter Pharma's shares in future funding rounds?
20
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
